DOYLESTOWN, Pa.--(BUSINESS WIRE)--QuantRx® Biomedical Corporation (OTCBB:QTXB), a diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide point-of-care healthcare industry, today announced that, in conjunction with its strategic partner, ALT BioScience, QuantRx' Senior Scientist, Dr. Tony Burgess-Cassler, presented his work on developing a new method for the rapid detection of oral disease at the 2009 International Association for Dental Research (IADR) Conference in Miami, Florida. The conference, held in early April, represented the most significant international dental research conference, attracting over 6,000 participants and showcasing the latest breakthroughs in dental research and technology. The presentation was also made at the April International Society for Breath and Odor Research (ISBOR) Conference held in Dortmund, Germany.
